Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
60.13
+1.97 (3.39%)
Nov 4, 2024, 4:00 PM EST - Market closed
Korro Bio Employees
As of December 31, 2023, Korro Bio had 102 total employees, including 101 full-time and 1 part-time employees.
Employees
102
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$836,284
Market Cap
559.14M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 102 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Community Health Systems | 61,000 |
Varex Imaging | 2,400 |
Talkspace | 472 |
Quanterix | 441 |
Surmodics | 376 |
Simulations Plus | 197 |
Tango Therapeutics | 140 |
Monte Rosa Therapeutics | 133 |
KRRO News
- 21 hours ago - Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - GlobeNewsWire
- 5 weeks ago - Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society - GlobeNewsWire
- 2 months ago - Korro to Participate in Upcoming September Investor and Scientific Conferences - GlobeNewsWire
- 2 months ago - Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - Korro to Participate in Upcoming June Investor and Scientific Conferences - GlobeNewsWire
- 6 months ago - Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference - GlobeNewsWire
- 6 months ago - Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer - GlobeNewsWire
- 7 months ago - Korro Announces $70 Million Private Placement - GlobeNewsWire